Home > Healthcare > Pharmaceuticals > Finished Drug Form > Blood Platelets Market

Blood Platelets Market Size

  • Report ID: GMI2849
  • Published Date: Sep 2024
  • Report Format: PDF

Blood Platelets Market Size

Blood Platelets Market size was valued at USD 5.6 billion in 2023 and is expected to exhibit growth at a CAGR of 4.2% from 2024 to 2032. The increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions are significantly driving the market growth.

 

The growing incidence of chronic and blood-related disorders is a key factor driving the expansion of the market. Conditions such as cancer, cardiovascular diseases, and hemophilia frequently result in platelet deficiencies, fueling the need for platelet transfusions. Factors behind this trend include an aging population, lifestyle-related health issues, and increasing cancer rates. For instance, according to the World Health Organization, cardiovascular diseases are responsible for 17.9 million deaths annually, many involving platelet therapies. As the prevalence of these chronic and blood-related disorders continues to rise, the demand for blood platelets is expected to grow, further driving the market's expansion in the coming years.
 

Moreover, the growing demand for blood transfusions diagnostics, particularly in trauma cases and surgical procedures, is further propelling the need for blood platelets. This increasing reliance on platelet transfusions is expected to significantly contribute to the sustained growth of the blood platelets market.
 

Blood platelets are small, disc-shaped cell fragments in the blood that play a crucial role in hemostasis, the process of stopping bleeding. They are produced in the bone marrow from larger cells called megakaryocytes and lack a nucleus, making them unique among blood components.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Blood platelets market size was USD 5.6 billion in 2023 and is expected to register 4.2% CAGR from 2024-2032 due to the increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions worldwide.

Blood platelets industry from the apheresis derived platelets segment reached USD 3 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to allowing for the collection of a larger number of platelets from a single donor compared to whole-blood donations.

North America blood platelets industry reached USD 1.5 million in 2023 and is expected to register 2.8% CAGR from 2024-2032 due to significant incidence of blood disorders such as leukemia and lymphoma in the region.

French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, Japanese Red Cross Society, OneBlood, Red Cross Society of China, South African Red Cross, Spanish Red Cross, and The European Blood Alliance (EBA), are some of the major blood platelets companies worldwide.

Blood Platelets Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 161
  • Countries covered: 23
  • Pages: 100
 Download Free Sample